title: Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?
abstract: Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.
  
  
  CONCLUSIONS
  With the availability of these very effective therapeutic options, an improved knowledge of these methods and their indications is required.
authors.affiliation: Department of Paediatric Cardiology, University Children's Hospital, Zurich, Switzerland. bauersfe@kispi.unizh.ch
authors.forename: U
authors.initials: U
authors.lastname: Bauersfeld
authors.forename: J P
authors.initials: JP
authors.lastname: Pfammatter
authors.forename: E
authors.initials: E
authors.lastname: Jaeggi
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D002648:Child; D006801:Humans; D013617:Tachycardia, Supraventricular / Q000503:physiopathology / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents